💡Enable 1.5 is a pioneering CEPI-supported study aiming to advance our understanding of Lassa fever virus and help inform Lassa vaccine development efforts. Read the study protocol, now published in The BMJ Public Health: bmjpublichealth.bmj.com/content/3/2/e0… 📸NCDC

We are thrilled to kick off the 3rd quarterly follow-up & blood sampling for the #ENABLEProject at AEFUTHA after a one-day refresher supported by the ENABLE Coordination Office at NCDC and CEPI. This collaboration is driving the generation of critical scientific

A commendable step by the ENABLE 1.5 team @NCDC in strengthening collaboration with AEFUTHA. Such visits are vital for reinforcing partnerships and ensuring the success of the vaccine study. Weldone Team 💪🏾

As emerging infectious diseases rise, the need to strengthen surveillance, diagnostics, and healthcare access is more urgent than ever. Despite years of research, #Lassa fever’s true burden remains unclear due to weak systems and limited data. #ELFC2025

In collaboration with CEPI , We are glad to commence the 4th and last quarterly blood sampling of enrolled study participants for the Enable project at Federal medical Centre Owo (FMCO) and Irrua specialist teaching hospital (ISTH). This also coincided with the CEPi

We are thrilled to kick off the last quarter of blood sampling exercise and participant follow up for the Enable Project AEFUTHA , supported by the Enable Coordination Office NCDC and @CEPIVaccine. Collaborating to generate critical scientific data to accelerate vaccine

#Lassa fever is a viral disease commonly spread through contaminated food, household items, or contact with infected individuals. ✅Prevention starts with you. Avoid physical contact with anyone showing symptoms. #LassaFever #StaySafe #NCDCNigeria

Today, CEPI convened a briefing on its next five-year strategy, CEPI 3.0, backed by an additional $2.5 billion investment campaign to advance global epidemic and pandemic preparedness. CEPI 3.0 builds on years of experience and places the 100 Days Mission at its core,

As the ENABLE 1.5 Project gradually winds down, we are marking yet another important milestone. Following accountability checks conducted by the Compliance Partner across the three ENABLE study sites, over 4,900 samples have been successfully shipped from ISTH and FMCO to NRL

In collaboration with CEPIvaccines, the ENABLE study Coordination team at the NCDC have marked another Milestone in the The ENABLE 1.5 Project. Following serum samples accountability checks by the Compliance Partner across the three ENABLE study sites, over 7,800 samples

After five decades of outbreaks, the race for the world’s first Lassa fever vaccine is no longer distant. For Nigeria, this is a moment to lead. In this #NHWPost, Shalom David & Uwaifiokun Okhuarobo examine how CEPI 3.0 could help accelerate Lassa vaccine development and why

Yesterday marked another major milestone in the ENABLE Programme! The Nigeria Centre for Disease Control and Prevention ENABLE Coordination Office has officially launched the ENABLE 1.5 Social Behavioral Study (SBS), a qualitative study designed to explore community attitudes,

🗓️We are excited to announce the commencement of the expanded ENABLE 1.5 Project in ATBUTH Bauchi. Building on the success recorded across our initial three states, this next phase marks another important step in strengthening our understanding of Lassa fever incidence in

Last week I visited Shanghai, China and spoke at the International Forum for Co-Creating the Future of Global Health with China MedTech, hosted by @GHII_org and Duke Kunshan University. My talk was about, "From Innovation to Impact: Scaling Affordable Diagnostic Technology in Emerging

Following the successful training of all study staff, we are pleased to announce the commencement of participant enrollment for the ENABLE 1.5 Project, Bauchi (Bauchi ENABLE) in partnership with CEPI. This study will deepen our understanding of #LassaFever by assessing